Docket Room.
SF 5187·MN·senate

Use of step therapy protocols prohibition for the treatment of neurological conditions

FailedFiled Apr 21, 2026
Sponsor: Mann
Latest Action

Author added

Apr 22, 2026

Email me when SF 5187 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SF 5187. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill bars health insurers from forcing patients with neurological disorders to follow step‑therapy protocols when a prescribed drug is FDA‑approved and listed on the plan’s formulary. It applies only when the drug’s use matches its FDA indication and a clinical practice guideline. The rule takes effect on Jan. 1, 2027 for plans issued or renewed after that date.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SF 5187

3 free questions a day, no account

History

  1. Author added Boldon
  2. Referred to Commerce and Consumer Protection
  3. Introduction and first reading

Sponsors

  • Mann · sponsor
  • Boldon

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SF 5187 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SF 5187 free

Or ask your AI assistant about SF 5187 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice